[go: up one dir, main page]

NO20064422L - Krystallinske former av 5,11-dihydro-11-etyl-5-metyl-8{2-{(1-oksido-4-kinolin 1)oksy}etyl}-6H-dipyrido[3,2-B:2',3'-E][1,4]diazepin--on - Google Patents

Krystallinske former av 5,11-dihydro-11-etyl-5-metyl-8{2-{(1-oksido-4-kinolin 1)oksy}etyl}-6H-dipyrido[3,2-B:2',3'-E][1,4]diazepin--on

Info

Publication number
NO20064422L
NO20064422L NO20064422A NO20064422A NO20064422L NO 20064422 L NO20064422 L NO 20064422L NO 20064422 A NO20064422 A NO 20064422A NO 20064422 A NO20064422 A NO 20064422A NO 20064422 L NO20064422 L NO 20064422L
Authority
NO
Norway
Prior art keywords
ethyl
dipyrido
diazepin
oxido
dihydro
Prior art date
Application number
NO20064422A
Other languages
English (en)
Norwegian (no)
Inventor
Carl A Busacca
Michael Cerreta
Richard Varsolona
John Smoliga
Jon Lorenz
Jana Vitous
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34963561&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20064422(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20064422L publication Critical patent/NO20064422L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20064422A 2004-04-02 2006-09-29 Krystallinske former av 5,11-dihydro-11-etyl-5-metyl-8{2-{(1-oksido-4-kinolin 1)oksy}etyl}-6H-dipyrido[3,2-B:2',3'-E][1,4]diazepin--on NO20064422L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55935404P 2004-04-02 2004-04-02
PCT/US2005/009655 WO2005097796A2 (fr) 2004-04-02 2005-03-23 Formes cristallines de 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxydo-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

Publications (1)

Publication Number Publication Date
NO20064422L true NO20064422L (no) 2006-09-29

Family

ID=34963561

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064422A NO20064422L (no) 2004-04-02 2006-09-29 Krystallinske former av 5,11-dihydro-11-etyl-5-metyl-8{2-{(1-oksido-4-kinolin 1)oksy}etyl}-6H-dipyrido[3,2-B:2',3'-E][1,4]diazepin--on

Country Status (19)

Country Link
US (1) US7309700B2 (fr)
EP (1) EP1740586A2 (fr)
JP (1) JP2007530681A (fr)
KR (1) KR20070014164A (fr)
CN (1) CN1938306A (fr)
AR (1) AR048360A1 (fr)
AU (1) AU2005230922A1 (fr)
BR (1) BRPI0509586A (fr)
CA (1) CA2558817A1 (fr)
EA (1) EA200601816A1 (fr)
EC (1) ECSP066904A (fr)
IL (1) IL178352A0 (fr)
MX (1) MXPA06011324A (fr)
NO (1) NO20064422L (fr)
PE (1) PE20060164A1 (fr)
TW (1) TW200602340A (fr)
UY (1) UY28827A1 (fr)
WO (1) WO2005097796A2 (fr)
ZA (1) ZA200605930B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101541327A (zh) * 2006-01-31 2009-09-23 塔利昂制药公司 法呢基二苯并二氮杂酮的晶体形式
CN109384765A (zh) * 2012-09-26 2019-02-26 默沙东公司 逆转录酶抑制剂的晶型

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI270547B (en) 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
US6759533B2 (en) 2002-06-28 2004-07-06 Boehringer Ingelheim Pharmaceuticals, Inc. Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors

Also Published As

Publication number Publication date
PE20060164A1 (es) 2006-04-03
AR048360A1 (es) 2006-04-19
MXPA06011324A (es) 2007-03-21
KR20070014164A (ko) 2007-01-31
WO2005097796A3 (fr) 2006-01-05
TW200602340A (en) 2006-01-16
CA2558817A1 (fr) 2005-10-20
US20050222134A1 (en) 2005-10-06
AU2005230922A1 (en) 2005-10-20
EP1740586A2 (fr) 2007-01-10
CN1938306A (zh) 2007-03-28
US7309700B2 (en) 2007-12-18
ECSP066904A (es) 2006-12-20
JP2007530681A (ja) 2007-11-01
WO2005097796A2 (fr) 2005-10-20
BRPI0509586A (pt) 2007-10-09
IL178352A0 (en) 2007-02-11
ZA200605930B (en) 2007-12-27
EA200601816A1 (ru) 2007-04-27
UY28827A1 (es) 2005-10-31

Similar Documents

Publication Publication Date Title
ZA200701533B (en) Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether
WO2008120725A1 (fr) Nouveau dérivé de pyrrolinone et composition médicale le contenant
NO20090172L (no) Substituert spiroketalderivat og anvendelse derav som legemiddel for a behandle diabetes
TW200744588A (en) Pharmaceutical composition for external use
WO2007048066A3 (fr) Pyrazolopyrimidines en tant que modulateurs de caseine kinase ii (ck2)
EG23719A (en) New process for the synthesis of (I S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and application in the synthesis of I V abradine and addition salts thereof witha pharmaceutically acceptable acid
UA94065C2 (en) Dihydropseudoerythromycin derivatives
WO2005021544A3 (fr) Inhibiteurs d'un ensemble d'imidazopyridine c n3 substitue
WO2009018065A3 (fr) Nouveaux activateurs de glucokinase et procédés pour les utiliser
WO2007075964A8 (fr) Antagonistes de recepteur de thrombine en tant que phophylaxie aux complications de derivation cardiopulmonaire
WO2008093838A1 (fr) Dérivé de pyridyl imidazolidine ayant un groupe sulfamoyle, et utilisation pharmaceutique de ce dérivé
WO2007011878A8 (fr) Antagonistes la vasopressine, du type beta-lactamyl phenylalanine, cysteine et serine
ZA200900165B (en) 4-amino-3-arylamino-6-arylpyrazolo[3,4-D]pyrimidine derivatives, methods for their preparation and their use as antiviral agents
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
DK1750703T3 (da) Fremgangsmåde til at reducere gastrointestinal toksitet forårsaget af indgivelsen af tegafur
NO20064422L (no) Krystallinske former av 5,11-dihydro-11-etyl-5-metyl-8{2-{(1-oksido-4-kinolin 1)oksy}etyl}-6H-dipyrido[3,2-B:2',3'-E][1,4]diazepin--on
EP1784402A4 (fr) Derives pyrrolo[3,2-c]pyridine et procedes de preparation de ces derniers
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
CY2011018I1 (el) Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος
WO2007010356A3 (fr) Procede pour la preparation de derives de sulfonamide
NO20053368D0 (no) Fremgangsmate for fremstilling av en farmasoytisk ren polymorf I av olanzapin.
WO2006036932A3 (fr) Sulfonamides et leurs utilisations
MX2007002833A (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios.
MY140538A (en) Substituted n-acyl-2-aminothiazoles
CR8981A (es) Derivados piridinicos de indolin-2-ona, su preparacion y su aplicacion en terapeutica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application